Taipei, Tuesday, July 22, 2014 23:39 (GMT+8)
light rain shower
Taipei
28°C
Apex sees increase in revenues, but drop in profits in 2013 - related company info
Patty Wang, Taipei; Joseph Tsai, DIGITIMES [Thursday 26 June 2014]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$63.6 on the TSE on Monday, July 21, 2014.
    The company has reported consolidated revenues of NT$154 million for June 2014, representing a 3.9% drop on month and 8.9% increase on year.
    For the first quarter of 2014, the company totaled NT$423 million in consolidated revenues, up 19.4% sequentially and down 19.2% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    22-Jul 797   63.70 64.00 63.00 63.00-0.60-0.94%  
    21-Jul 157 131 10,057,643 63.50 63.90 63.40 63.60+0.30+0.47% 63.60 63.50
    18-Jul 177   63.00 63.70 63.00 63.30+0.00+0.00%  
    17-Jul 177 120 11,229,100 64.00 64.00 63.30 63.30-0.30-0.47% 63.40 63.30
    16-Jul 88 80 5,627,588 64.20 64.20 63.60 63.60-0.20-0.31% 63.70 63.60
    15-Jul 114 85 7,230,260 63.50 63.80 63.40 63.80+0.50+0.79% 63.80 63.70
    14-Jul 120 101 7,572,716 62.90 63.50 62.80 63.30+0.50+0.80% 63.40 63.30
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Jun 2013 - Jun 2014 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Jun-14

    154

    (3.9%)

    8.9%

    865

    (15.2%)

    May-14

    161

    25.9%

    (7%)

    711

    (19.1%)

    Apr-14

    127

    (7.8%)

    (30.1%)

    551

    (22%)

    Mar-14

    138

    9.7%

    (25.6%)

    423

    (19.2%)

    Feb-14

    126

    (20.7%)

    (20.4%)

    285

    (15.7%)

    Jan-14

    159

    26.5%

    (11.6%)

    159

    (11.6%)

    Dec-13

    126

    9.8%

    (20.5%)

    1,829

    (9.7%)

    Nov-13

    114

    (0%)

    (27.8%)

    1,704

    (8.8%)

    Oct-13

    114

    (25.9%)

    (30.9%)

    1,589

    (7%)

    Sep-13

    154

    0.3%

    8.4%

    1,475

    (4.5%)

    Aug-13

    154

    5.6%

    0.2%

    1,320

    (5.8%)

    Jul-13

    146

    3%

    (8.8%)

    1,166

    (6.5%)

    Jun-13

    142

    (17.9%)

    (14.3%)

    1,021

    (6.2%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, July 2014

    Apex: Consolidated revenues, 1Q13 - 1Q14 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    1Q-14

    423

    19.4%

    (19.2%)

    423

    (19.2%)

    4Q-13

    354

    (22%)

    (26.5%)

    1,829

    (9.7%)

    3Q-13

    454

    (8.5%)

    (0.4%)

    1,475

    (4.5%)

    2Q-13

    497

    (5.2%)

    (9.9%)

    1,021

    (6.2%)

    1Q-13

    524

    8.7%

    (2.4%)

    524

    (2.4%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, July 2014

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 1Q13 - 1Q14 (NT$k)

    Item

    1Q-2014

    4Q-2013

    3Q-2013

    2Q-2013

    1Q-2013

    Current assets

    1,484,403

    1,447,851

    1,347,766

    1,644,885

    1,922,635

    Intangible assets

    25,088

    26,174

    17,236

    17,816

    14,190

    Non-current assets

    1,267,321

    1,276,137

    1,341,620

    1,027,811

    967,210

    Assets

    2,751,724

    2,723,988

    2,689,386

    2,672,696

    2,889,845

    Current liabilities

    347,770

    383,354

    382,837

    416,522

    353,703

    Non-current liabilities

    420,792

    420,118

    421,334

    421,188

    419,978

    Liabilities

    768,562

    803,472

    804,171

    837,710

    773,681

    Stockholders' equity

    1,983,162

    1,920,516

    1,885,215

    1,834,986

    2,116,164

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, July 2014

    Apex: Consolidated income statement, 1Q13 - 1Q14 (NT$k)

    Item

    1Q-2014

    4Q-2013

    3Q-2013

    2Q-2013

    1Q-2013

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Operating revenue

    423,222

     

    354,410

     

    454,277

     

    496,560

     

    523,974

     

    Gross profit (loss) from operations

    113,997

     

    106,527

     

    120,929

     

    169,175

     

    171,812

     

    Operating expenses

    54,100

     

    59,426

     

    51,361

     

    56,054

     

    52,611

     

    Operating income (loss)

    59,897

     

    48,747

     

    67,922

     

    113,121

     

    119,201

     

    Non-operating expenses and losses

    12,345

     

    -3,812

     

    -8,211

     

    63,611

     

    25,800

     

    Income from continuing operations before income tax

    72,242

     

    44,935

     

    59,711

     

    176,732

     

    145,001

     

    Net income (loss)

    62,129

     

    30,322

     

    51,591

     

    163,005

     

    125,925

     

    Diluted earnings per share (NT$)

    0.6

     

    0.3

     

    0.5

     

    1.6

     

    1.2

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, July 2014

  • Apex Biotechnology full profile
Realtime news
  • E Ink Holdings sells CPT convertible bonds

    Before Going to Press | 1h 53min ago

  • Commentary: Microsoft moves to eliminate Nokia

    Before Going to Press | 1h 58min ago

  • Investment in production of N-type monocrystalline solar cells may take off in 2-3 years

    Before Going to Press | 2h 1min ago

  • TPCA urges Taiwan government to upgrade PCB industry

    Before Going to Press | 2h 23min ago

  • Fujitsu Taiwan to cooperate with university to set up Big Data R&D platform

    Before Going to Press | 2h 33min ago

  • Digitimes Research: Demand for sapphires for optical use estimated at 12.44 million mm in 2014

    Before Going to Press | 2h 37min ago

  • China market: Xiaomi launches new flagship smartphone

    Before Going to Press | 2h 38min ago

  • Bay Zu Precision to showcase roll-to-roll vacuum sputtering systems at Touch Taiwan 2014

    Before Going to Press | 2h 39min ago

  • TSMC to offer more wafer starts to MediaTek in 3Q14

    Before Going to Press | 2h 40min ago

  • Apple new iPhones to come with different time tables to avoid competition

    Before Going to Press | 2h 42min ago

  • Digitimes Research: Global tablet shipments reach 55.06 million units in 2Q14

    Before Going to Press | 2h 48min ago

  • Innolux, AUO facing competition from South Korea-based Ultra HD TV makers in China

    Before Going to Press | 3h 26min ago

  • USI reportedly lands SiP module orders for iWatch devices

    Before Going to Press | 3h 43min ago

  • Chi Mei Materials starts construction of polarizer factory in China

    Before Going to Press | 3h 49min ago

  • Taiwan server ODMs may benefit from Project Scorpio 2.0 to begin in September

    Before Going to Press | 4h 27min ago

  • Microsoft facing increased competition from MacBook, Chromebook, say Taiwan makers

    Before Going to Press | 5h 1min ago

Pause
 | 
View more

21-Jul-2014 markets closed

 LastChange

TAIEX (TSE)9400.97-7.27-0.08% 

TSE electronic370.47-0.65-0.18% 

GTSM (OTC)147.84-0.32-0.22% 

OTC electronic182.98-1.06-0.58% 

DIGITIMES Translation Services
Greater China touch panel shipment forecast through 2015